Abstract
As more individuals receive outer surface protein A (OspA) vaccination, adverse effects not detected during phase III clinical trials may become apparent. Although arthritis has been described following other human vaccines, we found no reports of human cases after Lyme disease vaccination. We describe 4 males (2 children, 2 adults) who developed arthritis following recombinant OspA vaccination. The potential arthritogenic effect of OspA suggested by in vitro and animal studies finds a clinical correlate in these 4 cases.
| Original language | English |
|---|---|
| Pages (from-to) | 2555-2557 |
| Number of pages | 3 |
| Journal | Journal of Rheumatology |
| Volume | 28 |
| Issue number | 11 |
| State | Published - 2001 |
| Externally published | Yes |
Keywords
- Arthritis
- Lyme vaccine
Fingerprint
Dive into the research topics of 'Arthritis following recombinant outer surface protein A vaccination for lyme disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver